Form4insider filings, from the source

SEC Form 4 · accession 0001302110-26-000032

Fulgent Genetics, Inc. · FLGT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ming Hsieh
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Sep 1, 2026
Accepted (ET)
Sep 3, 2026 · 7:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001674930

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Sep 1, 2026F4,392$19.59D885,952D
Common StockF2holding———7,895,115IBy Trust
Common StockF3holding———220,816IBy Trust
Common StockF4holding———1,000IUniform Transfer to Minor Account
Common StockF5holding———1,000IBy Immediate Family

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses